U1-nRNP antibodies test

What is U1-nRNP antibodies test? 

U1-nRNP antibodies, also known as anti-RNP or anti-ribonucleoprotein antibodies, are a type of autoantibodies produced against ribonucleoprotein (RNP) - one of the proteins present in the nucleus of every cell of our body.

Normally, our immune system produces antibodies against invading foreign substances, such as bacteria or viruses. However, sometimes the immune system mistakes our own tissues or cells as harmful and starts producing antibodies against them. These antibodies are called autoantibodies. The presence of autoantibodies is usually associated with autoimmune diseases.

U1-nRNP antibodies are found in 95-100% of people with mixed connective tissue disease (MCTD). MCTD is a rare autoimmune condition characterised by a combination of features of the following disorders:

• Systemic lupus erythematosus (SLE): It is a long-term autoimmune condition that leads to inflammation of certain connective tissues, such as cartilage and the walls of blood vessels. U1-nRNP antibodies and anti-Sm (anti-Smith) antibodies are seen in about 20-30% of people with SLE. (Read more: Anti-Sm antibody test)
• Polymyositis: Polymyositis is an autoimmune inflammatory disease that affects the muscles and tissues associated with it, for example, the blood vessels that supply the muscles.
• Scleroderma: It is an autoimmune condition which causes thickening and tightening of the skin along with scarring of body tissues. Scleroderma may sometimes be referred to as progressive systemic sclerosis (PSS). About 20-25% of people with PSS may have U1-nRNP antibodies.

An ANA (anti-nuclear antibody) test is usually the first test performed to detect an autoimmune condition. If an individual has a positive ANA test, then an extractable nuclear antigen (ENA) panel test is performed to check for the type of autoimmune condition. The U1-nRNP antibodies test is one of the ENA panel tests that is done to confirm the presence of MCTD in suspected individuals.

1. Kavanaugh Arthur, Tomar Russell, Reveille John, Solomon Daniel, and Homburger Henry A. Guidelines for Clinical Use of the Antinuclear Antibody Test and Tests for Specific Autoantibodies to Nuclear Antigens. Archives of Pathology & Laboratory Medicine. 2000 Jan;124(1):71-81.
2. Aggarwal Amit. Role of autoantibody testing. Best Practices and Research Clinical Rheumatology. 2014 Dec;28(6):907-920.
3. Ortega-Hernandez O.D. and Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment.. Best Pract Res Clin Rheumatol. 2012 Feb;26(1):61-72. PMID: 22424193.
4. Office on women's health [internet]: US Department of Health and Human Services; Autoimmune diseases
5. National Institute of Arthritis and Musculoskeletal and Skin Diseases [internet]: National Institute of Health. US Department of Health and Human Services; Autoimmune Diseases
6. National Institute of Allergies and Infectious diseases [internet]: National Institute of Health. US Department of Health and Human Services; Autoimmune Diseases
7. MedlinePlus Medical Encyclopedia [Internet]. US National Library of Medicine. Bethesda. Maryland. USA; Autoimmune Diseases
8. South Tees Hospitals. NHS Foundation trust. National Health Service, U.K.; Anti-RNP Antibody
9. Genetic and Rare Diseases Information Center [internet]. National Center for Advancing Translational Sciences. National Institute of Health. U.S. Department of Health and Human Services; Mixed connective tissue disease
10. Genetics Home Reference [internet]. National Institute of Health: US National Library of Medicine. US Department of Health and Human Services; Systemic lupus erythematosus
11. Muscular Dystrophy Association [Internet]. Muscular Dystrophy Association National Office. Chicago. Illinois. U.S.A.; Polymyositis (PM)
12. American College of Rheumatology [internet]. Rheumatology Research Foundation. Atlanta. Georgia. U.S.A.; Diseases and Conditions
13. Scleroderma Foundation [Internet]. Danvers. Massachusetts. U.S.A., What is scleroderma?
14. Petri M, Orbai A, Alarcon GS, et al. Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheum. 2012 August ; 64(8): 2677–2686.
15. Pagana, Kathleen D., Pagana, Timothy J., and Pagana, Theresa N. Mosby's Diagnostic and Laboratory Test Reference . 13th Edition: Mosby, Inc., Saint Louis, MO.
16. Lupus Foundation of America [internet]. Washington D.C. (U.S.); What you need to know about Sjogren’s Syndrome
17. Patel R, Shahan A. The epidemiology of Sjögren’s syndrome. Clinical Epidemiology. 2014 Jul;6:247-255.
18. Mason RJ, et al. Murray and Nadel's Textbook of Respiratory Medicine. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2016
19. National Heart, Lung, and Blood Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Raynaud's
20. Ferri FF. Ferri's Clinical Advisor 2018. Philadelphia, Pa.: Elsevier; 2018
21. Merck Manual Professional Version [Internet]. Kenilworth (NJ): Merck & Co. Inc.; c2019. Mixed Connective Tissue Disease (MCTD)
22. National Health Service [internet]. UK; Blood Tests
23. R Rich, T Fleisher, B Schwartz, et al. Clinical Immunology: Principles and Practice. First edition. St. Louis, Mosby-Year Book. 2008.
24. Johns Hopkins Medicine [Internet]. The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System; Lupus Blood Tests
25. Genetics Home Reference [internet]. National Institute of Health: US National Library of Medicine. US Department of Health and Human Services; Rheumatoid arthritis